InsiderTrades.com logo
Emily Pimblett net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Emily Pimblett Biography and Net Worth

CAO of Climb Bio
Emily Pimblett is the CAO of Climb Bio.

What is Emily Pimblett's net worth?

The estimated net worth of Emily Pimblett is at least $170.37 thousand as of June 20th, 2025. Pimblett owns 18,888 shares of Climb Bio stock worth more than $170,370 as of April 23rd. This net worth estimate does not reflect any other assets that Pimblett may own. Learn More about Emily Pimblett's net worth.

How do I contact Emily Pimblett?

The corporate mailing address for Pimblett and other Climb Bio executives is 20 William Street Suite 145, Wellesley Hills MA, 02481. Climb Bio can also be reached via phone at 866-857-2596 and via email at [email protected]. Learn More on Emily Pimblett's contact information.

Has Emily Pimblett been buying or selling shares of Climb Bio?

Emily Pimblett has not been actively trading shares of Climb Bio within the last three months. Most recently, Emily Pimblett sold 1,242 shares of the business's stock in a transaction on Friday, June 20th. The shares were sold at an average price of $1.24, for a transaction totalling $1,540.08. Following the completion of the sale, the chief accounting officer now directly owns 18,888 shares of the company's stock, valued at $23,421.12. Learn More on Emily Pimblett's trading history.

Are insiders buying or selling shares of Climb Bio?

In the last twelve months, Climb Bio insiders bought shares 3 times. They purchased a total of 321,672 shares worth more than $779,625.64. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 1,242 shares worth more than $1,540.08. The most recent insider tranaction occured on January, 5th when Director Ra Capital Management, L.P. bought 7,111 shares worth more than $24,888.50. Insiders at Climb Bio own 0.8% of the company. Learn More about insider trades at Climb Bio.

Information on this page was last updated on 1/5/2026.

Emily Pimblett Insider Trading History at Climb Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/20/2025Sell1,242$1.24$1,540.0818,888View SEC Filing Icon  
3/20/2025Sell1,199$1.31$1,570.6915,130View SEC Filing Icon  
12/19/2024Sell1,235$2.02$2,494.7011,329View SEC Filing Icon  
See Full Table

Emily Pimblett Buying and Selling Activity at Climb Bio

This chart shows Emily Pimblett's buying and selling at Climb Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Climb Bio Company Overview

Climb Bio logo
Climb Bio Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody which has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Climb Bio Inc., formerly known as Eliem Therapeutics Inc., is based in WELLESLEY, Mass.
Read More

Today's Range

Now: $9.02
Low: $8.71
High: $9.44

50 Day Range

MA: $7.12
Low: $5.27
High: $9.37

2 Week Range

Now: $9.02
Low: $1.13
High: $10.00

Volume

487,650 shs

Average Volume

628,999 shs

Market Capitalization

$430.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A